title: Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.
abstract: Recent evidence suggests a potential role for thrombospondin-2 (TSP-2), a matricellular glycoprotein, in the regulation of primary angiogenesis. To directly examine the biological effect of TSP-2 expression on tumor growth and angiogenesis, human A431 squamous cell carcinoma cells, which do not express TSP-2, were stably transfected with a murine TSP-2 expression vector or with vector alone. A431 cells expressing TSP-2 did not show an altered growth rate, colony-forming ability, or susceptibility to induction of apoptosis in vitro. However, injection of TSP-2-transfected clones into the dermis of nude mice resulted in pronounced inhibition of tumor growth that was significantly stronger than the inhibition observed in A431 clones stably transfected with a thrombospondin-1 (TSP-1) expression vector, and combined overexpression of TSP-1 and TSP-2 completely prevented tumor formation. Extensive areas of necrosis were observed in TSP-2-expressing tumors, and both the density and the size of tumor vessels were significantly reduced, although tumor cell expression of the major tumor angiogenesis factor, vascular endothelial growth factor, was maintained at high levels. These findings establish TSP-2 as a potent endogenous inhibitor of tumor growth and angiogenesis.
authors.affiliation: Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
authors.forename: M
authors.initials: M
authors.lastname: Streit
authors.forename: L
authors.initials: L
authors.lastname: Riccardi
authors.forename: P
authors.initials: P
authors.lastname: Velasco
authors.forename: L F
authors.initials: LF
authors.lastname: Brown
authors.forename: T
authors.initials: T
authors.lastname: Hawighorst
authors.forename: P
authors.initials: P
authors.lastname: Bornstein
authors.forename: M
authors.initials: M
authors.lastname: Detmar
mesh_terms: D020533:Angiogenesis Inhibitors / Q000378:metabolism*; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control*; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009374:Neoplasms, Experimental / Q000517:prevention & control*; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D011994:Recombinant Proteins / Q000378:metabolism; D019699:Thrombospondins / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D000099262:Thrombospondin 2
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D019699:Thrombospondins; D000099262:Thrombospondin 2